article thumbnail

Excimer Laser Coronary Angioplasty

All About Cardiovascular System and Disorders

The most important advantage of laser angioplasty or excimer laser angioplasty, is that you need only a standard guidwire, 0.014 inch standard guide wire, unlike the other atherectomy devices which require a bulkier guidewire. Diagrammatic representation of laser angioplasty or atherectomy. One is in-stent restenosis.

article thumbnail

Intravascular Ultrasound Outperforms Angiography for Peripheral Artery Disease Treatment

DAIC

The study, called IVUS-DCB, is the first randomized controlled trial to demonstrate the clinical benefits of using IVUS in angioplasty procedures for peripheral artery disease (PAD), a condition in which plaque builds up in arteries in the legs. of patients who received IVUS and 70.1%

article thumbnail

Understanding the Difference Between Heart Attack and Cardiac Arrest

MIBHS

This blockage is often caused by a blood clot or the buildup of plaque in the coronary arteries, which supply the heart with oxygen-rich blood. A heart attack, or myocardial infarction, happens when an artery becomes blocked, reducing blood flow to the heart muscle.

article thumbnail

Boston Scientific Receives FDA Approval for the AGENT Drug-Coated Balloon

DAIC

ISR is the obstruction or narrowing of a stented vessel by plaque or scar tissue. 3 In the prespecified interim analysis of the first 480 patients enrolled, the study met the primary endpoint of target lesion failure (TLF) at 12 months with the AGENT DCB demonstrating statistical superiority to uncoated balloon angioplasty (17.9%

Stents 105
article thumbnail

Simpson Interventions Receives FDA Breakthrough Device Designation for Acolyte Image Guided Crossing and Re-Entry Catheter System

DAIC

If a physician fails to cross a CTO, minimally invasive revascularization options such as angioplasty and stent placement cannot be performed. Hence, in the US, many CTO patients are instead sent for bypass surgery.

article thumbnail

25th Anniversary of a landmark study in coronary revascularization

Dr. S. Venkatesan MD

This study tested PTCA vs with a single lipid lowering drug in terms of plaque regression. One clue : We do prescribe this drug every day and it beats angioplasty. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Can you name this trial that can withstand any period of time?

article thumbnail

SCAI, SIR, and SVS Jointly Publish Proceedings from Multispecialty Peripheral IVUS Roundtable

DAIC

It provides detailed information about the vessel wall, plaque composition, and blood flow characteristics, enabling more accurate diagnosis and treatment planning. During the roundtable, participants highlighted the potential of IVUS in guiding revascularization procedures, such as angioplasty and stenting, to optimize outcomes for patients.